Children
living near Superfund sites may be exposed
to ground water contaminated with neurotoxicants,
which may pose a special health risk
because the brain is thought to be particularly
vulnerable during childhood. Low-level
toxicant exposures may cause subtle
and difficult to detect neurological
defects that lead to learning disabilities
or attention deficit disorders. The
goal of this project is to develop animal
models that can detect such deficits
following exposure to the low concentrations
of toxins typically found in ground
water near Superfund sites.
Based
on well-characterized experiments that
demonstrate the role of complex spatial
and social experience in brain growth
in rats, we have developed a screen
to test for faults in brain growth caused
by neurotoxicant exposure during development.
The general brain growth response correlates
well with cognitive ability. Progress
has been made on two major objectives:
to study the effects of chloroacetaldehyde
(CAA-a metabolite of the Superfund chemical
vinyl chloride) on brain growth, and
to refine our ability to detect specific
cellular deficits using methylazoxymethanol
(MAM). We have integrated our studies
in a collaboration with Drs. Karla Thrall
and Glen Kisby, who analyzed CAA metabolism
(Thrall) and CAA-induced DNA damage
in a variety of tissues (Kisby). We
found that CAA retention in the brain
is prolonged relative to its presence
in peripheral tissues. Studies measuring
the effects of CAA exposure on brain
development and DNA damage in liver,
brain and kidney are ongoing. Our goal
is that the protocol we establish for
assessing CAA effects in the brain and
other tissues can be applied in the
future to assess the effects of a wide
variety of compounds.
We have also made progress toward refining
our model to detect the adverse effects
of MAM. We are examining gene expression
associated with brain plasticity to
determine if this measure will reveal
signs of damage more rapidly than measures
of brain structure. We have also completed
both light and electron microscopic
quantitative analyses of the structure
of neurons to determine if developmental
exposure has a lasting effect on synapses
in brain regions important to cognition,
learning and memory. In rats dosed prenatally
with MAM, we have found that brain development
is diminished at dosages significantly
lower than those reported previously
using conventional assessments of brain
structure or behavior.
This study is important because it 1) demonstrates latent developmental
damage after low level exposure to an established neurotoxicant
(MAM) and 2) provides a new set of biomarkers for assessing low
dose effects of as yet uncharacterized compounds to which developing
humans are exposed. Our collaboration with other SBRP scientists
is significant because it 1) combines the expertise of multiple
labs to obtain a new battery of assessments; 2) maximizes the
data yield of an experiment; and 3) establishes an integrative
training environment for young scientists.